Skip to main content
OpenTrials
Completed

NCT Number: NCT01139060

Organized Self-Management Support Services for Chronic Depression

The purpose is to test the effectiveness of an organized care program for chronic or recurrent depression. Using a two-arm design, the investigators will randomly assign 300 participants with chronic or recurrent depression to one of two conditions: continued usual care (UC); or an 18-month organized treatment program focused on outreach and engagement, including a weekly group self-management training program, monthly visits with a psychotherapist (in-person or by telephone), and optional one-on-one visits with a peer support specialist. All intervention components are intended as adjuncts to any existing depression treatment (usually antidepressant medication) provided by participants' regular providers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms Bronchial Diseases Bronchiolitis Bronchiolitis Obliterans Bronchiolitis Obliterans Syndrome Bronchitis Graft vs Host Disease Immune System Diseases Lung Diseases Lung Diseases, Obstructive Organizing Pneumonia Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Group Health Research Insitute, Seattle, Washington, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients will meet criteria for recurrent major depression or dysthymia

Exclusion criteria

  • bipolar disorder or psychotic disorder

Treatment and study plan

organized care program for chronic or recurrent depression

Behavioral

Primary outcomes

  1. Evaluate the program's effectiveness, i.e., the effects of the intervention on patient outcomes (depressive symptoms, functional impairment, and disability/lost productivity) and process of care (self-efficacy and self-management behaviors)

    Time frame: 18 months

Secondary outcomes

  1. Examination of moderators of treatment response

    Time frame: 18 months

  2. An estimate of the program's costs and effect on the costs of treatment for depression

    Time frame: 18 months

Sponsors and collaborators

Lead sponsor

Kaiser Permanente

Other

Collaborators

  • Swedish Medical Center

Registry information

Acronym: Stride

Important dates

Study start
2009
Primary completion
2013
First posted
Jun 8, 2010
Registry last updated
Oct 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.